symposium
National Gender Medicine Symposium 2025
Date: 20 – 21 October 2025
Location: Kursaal, Bern
On October 20-21, 2025, the first Swiss Symposium on Gender Medicine will take place in the capital city of Bern. This high-caliber and widely supported event brings together leading experts, researchers, and medical professionals to discuss and exchange the latest developments and challenges in gender-specific medicine. Additionally, the latest findings, innovative approaches, and groundbreaking research projects will be presented.
The event aims to raise awareness of gender-specific differences in medicine and promote dialogue between professionals, researchers, and policymakers.
Why Gender Medicine?
Gender medicine deals with the biological and psychosocial differences between men and women and their impact on health. Research has shown that diseases are often diagnosed, treated, and experienced differently depending on gender. For example, women show different symptoms in heart attacks than men, leading to misdiagnosis and delayed treatment. A better understanding of these differences is crucial to ensure fair and effective healthcare.
Highlights of the Symposium
The symposium offers a variety of lectures, panel discussions, and workshops led by renowned experts:
Keynote Lectures:
Renowned experts present current research results and trends in gender medicine.
Panel Discussions:
Interactive discussions on topics such as gender-specific differences in cardiovascular diseases, cancer, mental illnesses, and more.
Workshops:
Practical sessions on diagnostic methods, therapy approaches, and prevention strategies.
Networking:
Meet colleagues from various medical disciplines and establish valuable connections.
Poster Presentations:
Discover innovative research projects and interact directly with the researchers.
1st Swiss Gender Medicine Symposium
Program is constantly updated.
Speakers
Prof. Dr. Loanda Schiebinger
For the launch of the 1st Swiss Symposium on Gender Medicine, we have secured Prof. Dr. Loanda Schiebinger from Stanford University, a leading global expert on gender medicine. She will deliver the opening address and present the latest findings from her research.
Kursaal Bern Congress Centre
-
Who Should Attend?This symposium is aimed at doctors, researchers, nurses, health managers, health policymakers, and medical students, as well as anyone interested in gender-specific aspects of healthcare.
-
Why Attend?Gender differences are crucial for diagnosis, treatment, and prevention in medicine. Our symposium highlights the latest scientific findings and practical applications in gender medicine. Leading experts from around the world will share their research and experiences to improve healthcare for all genders.
-
Practical Relevance and Future PerspectivesIn addition to theoretical insights, the symposium places great importance on the practical application of gender medicine in clinical practice. Workshops on topics such as "Gender-Specific Diagnostics" and "Therapy Adjustments in Gender Medicine" will provide doctors and medical staff with concrete tools to consider gender-specific differences in treatment.
-
A Platform for ExchangeThe symposium provides a valuable platform for exchange between scientists, doctors, representatives of the pharmaceutical industry, and health policymakers. The goal is to establish and strengthen networks and promote cooperation to advance research and application of gender medicine.
Registration and Further Information
The registration platform and program will be launched in spring 2025. Visit our website www.gender-medizin-symposium.ch for detailed information and to sign up for our newsletter.
Conclusion
The Swiss Symposium on Gender Medicine marks an important step towards gender-equitable healthcare. By focusing on the differences between men and women in medical research and practice, it helps reduce health inequalities and improve the quality of care for all patients.
The symposium forms the basis for further research and initiatives in gender medicine and connects different target groups nationally and internationally.